Premium
Coronary arterial disease in patients undergoing percutaneous edge‐to‐edge mitral valve repair: Handle with care
Author(s) -
Musumeci Giuseppe,
Colopi Marzia
Publication year - 2021
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.29660
Subject(s) - medicine , mitraclip , mitral regurgitation , cardiology , mitral valve repair , coronary artery disease , percutaneous , mitral valve , concomitant , revascularization , comorbidity , surgery , myocardial infarction
Key Points Percutaneous mitral valve repair using the MitraClip System is a revolutionary treatment option for patients with severe mitral regurgitation (MR) and prohibitive surgical risk. Coronary arterial disease is a frequent comorbidity in patients with severe MR. The impact of concomitant coronary artery disease and revascularization on outcome in patients undergoing transcatheter mitral valve repair is still an ongoing debate.